November 29, 2011Heart
Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy
Key result
Late gadolinium enhancement cardiovascular magnetic resonance is reviewed as a potential prognostic marker for adverse events in dilated and hypertrophic cardiomyopathy.
Why the study?
Does late gadolinium enhancement cardiovascular magnetic resonance predict adverse events in patients with dilated or hypertrophic cardiomyopathy?
Population
Patients with dilated cardiomyopathy or hypertrophic cardiomyopathy
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Should not yet change practice in cardiomyopathy; leaves open the need for prospective validation of late gadolinium enhancement CMR.
Structured PICO
Does late gadolinium enhancement cardiovascular magnetic resonance predict adverse events in patients with dilated or hypertrophic cardiomyopathy?
P
Population
Patients with dilated cardiomyopathy or hypertrophic cardiomyopathy
E
Exposure
Late gadolinium enhancement cardiovascular magnetic resonance
O
Outcome
Adverse events
Late gadolinium enhancement cardiovascular magnetic resonance is reviewed as a potential novel risk factor for predicting adverse events in dilated and hypertrophic cardiomyopathy.
Cite This Study
Ismail et al. (2011) conducted a review in Dilated and hypertrophic cardiomyopathy. Late gadolinium enhancement cardiovascular magnetic resonance was evaluated. Late gadolinium enhancement cardiovascular magnetic resonance is reviewed as a potential prognostic marker for adverse events in dilated and hypertrophic cardiomyopathy.